Juniper is a digital weight loss programme founded in 2021 by Australian health company Eucalyptus. It combines GLP-1 weight loss medications with clinician support, lifestyle coaching, and a tracking app, and has attracted over 260,000 members globally, with a primary focus on women.
Juniper’s own clinical data shows members lose an average of 23% of body weight in one year. Members are 4.5 times more likely to lose significant weight than with medication alone. The programme uses Wegovy (semaglutide) and Mounjaro (tirzepatide) as its core medications. No GP referral is required to join. Costs start from around 164 GBP per month in the UK.
This review covers how Juniper works, what results members actually achieve, how it compares to competitors like Voy, and what side effects to expect. It also explains what to do to protect your results long-term after the programme ends.
What Is Juniper?
Juniper is a digital weight management programme operated by Australian health company Eucalyptus, founded in 2021 and available in the UK, Australia, and selected markets with over 260,000 members worldwide, primarily women managing weight through GLP-1 medication combined with clinical coaching.
The programme operates without a GP referral. Members access a clinical team, medication, a digital app for progress tracking, and structured lifestyle coaching in a single subscription. Juniper positions itself as a comprehensive care model rather than a simple prescription service.
A breakthrough study published by Eucalyptus compared Juniper’s cohort against independent clinical trials. Juniper patients achieved superior weight loss outcomes despite paying out of pocket, while trial participants had treatment costs reimbursed.
How Does the Juniper Programme Work?
Juniper combines weight loss medication with a personalised digital care model that includes clinician consultations, a dedicated health app, exercise and nutrition guidance, and ongoing medication adjustment as members progress through the programme.
Members complete an online assessment, speak with a Juniper clinician, and receive a medication prescription tailored to their health profile and goals. The Juniper app tracks weight, habits, and medication adherence, while the clinical team adjusts dosing and support as needed.
The programme emphasises lifestyle habit change alongside medication. Structured tools for building lasting behaviours are built into the platform. Juniper’s model argues that medication alone is insufficient. Clinical data from the programme supports this position.
What Medications Does Juniper Use?
Juniper prescribes two GLP-1 weight loss medications: Wegovy (semaglutide) and Mounjaro (tirzepatide), both of which are once-weekly injectable treatments that suppress appetite, slow gastric emptying, and improve insulin sensitivity to drive significant weight loss.
Wegovy at its highest dose produces up to 20.7% body weight reduction in clinical trials. Mounjaro at its highest dose produces up to 20.9%. Both deliver comparable results within the Juniper framework, with selection depending on individual health profile and clinician assessment.
Clinicians at Juniper choose the medication and dose that fits each member’s health history, starting weight, and tolerance. Neither medication is one-size-fits-all. Dosing is titrated gradually from a starting level up to the effective maintenance range over several months.
Does Juniper Actually Help You Lose Weight?
Yes. Juniper’s own clinical study compared its cohort to participants in the SCALE and ADDRESS GLP-1 trials, finding Juniper members were 4.5 times more likely to achieve significant weight loss than patients in the ADDRESS clinical trial using the same medication without coaching support.
The multidisciplinary model, combining medication with clinician guidance, nutrition coaching, exercise planning, and app-based accountability, produces outcomes that exceed what medication alone achieves. The study was conducted over 32 weeks, a shorter period than the 43-52 week comparison trials.
Even in a shorter treatment window, Juniper members outperformed reimbursed clinical trial participants on key outcomes. This suggests the digital care model adds substantial clinical value on top of the GLP-1 medication’s pharmacological effects.
How Much Weight Do Juniper Members Lose?
Juniper members lose an average of 23% of their body weight in one year, based on data sourced from over 373,000 weight tracker entries in the Juniper app. This figure exceeds the clinical trial averages for both Wegovy and Mounjaro used without programme support.
At 32 weeks, the Juniper study found that nearly 90% of members lost at least 5% of body weight, nearly 60% lost at least 10%, and one-quarter lost at least 15%. Juniper members were twice as likely to lose at least 15% compared to participants in the phase 3 clinical trial of the same medication.
Individual results vary based on starting weight, medication dose, programme adherence, and lifestyle changes. Members who engage fully with the coaching, app, and dietary guidance consistently outperform those using medication alone.
How Quickly Do Results Start?
Most Juniper members begin experiencing appetite suppression within the first 1-4 weeks of starting GLP-1 medication, with visible weight loss typically appearing within 4-8 weeks of treatment as the medication reaches effective dose levels.
Medication starts at the lowest dose and is titrated upward every 4 weeks. Significant weight loss accelerates at higher doses. The Juniper app tracks progress weekly, and clinicians review member data to adjust medication and support as results develop.
Members who experience a plateau often benefit from Juniper’s clinician support to reassess dosing, dietary habits, or exercise routines. The coaching element distinguishes Juniper from providers that offer medication with minimal ongoing contact.
What Are the Benefits of Juniper?
Juniper delivers benefits beyond weight loss: improved metabolic health, reduced cardiovascular risk factors, better sleep quality, increased energy, and a structured support system that builds long-term lifestyle habits alongside medication-driven fat loss.
The programme’s core advantage is the integration of clinical and lifestyle support. Members do not simply receive a prescription and a pharmacy delivery. They receive ongoing clinician contact, exercise planning focused on muscle maintenance, and nutritional guidance tailored to their profile.
Juniper’s clinical study demonstrates that its members achieve better outcomes than those receiving the same medication in controlled trials. The programme’s structure and support system are the differentiating factors behind this performance gap.
Key Benefits of the Juniper Programme:
- Average 23% body weight reduction in one year
- Access to Wegovy and Mounjaro without GP referral
- Ongoing clinician support and medication adjustment
- App-based habit tracking and progress monitoring
- Exercise planning focused on muscle maintenance
- 4.5x better results than medication without coaching
Does Juniper Provide Ongoing Support?
Yes. Juniper provides continuous clinical support throughout the programme, including regular check-ins with clinicians, medication dose reviews, access to a digital support team, and structured tools for building dietary and exercise habits that persist beyond the programme itself.
Members access clinicians via the Juniper app during the programme, with the clinical team available 9am-5pm. The app logs weight, habits, and medication adherence, giving clinicians visibility into each member’s progress between consultations.
Support extends to managing side effects. Members experiencing GI discomfort, dose-related nausea, or other medication-related issues receive guidance from the Juniper team rather than navigating these challenges alone with a pharmacist.
What Are the Side Effects of Juniper Medication?
Juniper medications, specifically Wegovy and Mounjaro, most commonly cause gastrointestinal side effects including nausea, vomiting, diarrhea, constipation, and abdominal pain, typically mild and dose-dependent, improving over time as the body adjusts to GLP-1 treatment.
GI side effects are most pronounced during dose increases and in the first weeks of treatment. Most members find symptoms diminish significantly after the initial adjustment period. Juniper’s clinical team provides guidance on managing these effects through meal timing, hydration, and food choices.
Both Wegovy and Mounjaro carry risks beyond GI discomfort: pancreatitis, gallbladder disease, and kidney complications are documented risks with GLP-1 receptor agonists. Juniper clinicians conduct an eligibility assessment before prescribing to screen for contraindications.
Are There Serious Risks?
Yes. Both Wegovy and Mounjaro carry FDA and MHRA boxed warnings regarding thyroid C-cell tumor risk observed in animal studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2 (MEN2).
Pancreatitis is a documented risk with GLP-1 medications. Members with a history of pancreatitis, severe kidney disease, or serious GI disorders are typically not eligible for the Juniper Programme. Juniper’s eligibility assessment screens for these conditions before prescribing.
Extreme appetite suppression at higher doses can reduce food intake to levels that create nutritional deficiencies. Members at risk of disordered eating patterns require careful monitoring. Juniper’s programme-based support model provides a layer of oversight that a standalone prescription does not.
Who Is Juniper Designed For?
Juniper is primarily designed for women seeking medically supervised weight loss, typically adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or sleep apnea.
The programme is accessible without a GP referral. Juniper’s online eligibility assessment and clinician consultation replaces the traditional referral pathway. This pathway provides faster access to GLP-1 medication than NHS or standard private GP routes.
Juniper has attracted over 260,000 members globally since 2021. The programme is predominantly aimed at women and has an average Trustpilot rating of 4.5 based on over 9,000 reviews, reflecting broadly positive user experiences with both the medication and programme support.
Can You Get Juniper Without a GP Referral?
Yes. Juniper operates independently of the traditional GP referral system, with all eligibility assessments, consultations, and prescriptions handled by Juniper’s own clinical team, which means members can start the programme without first seeing their NHS or private GP.
Members complete an online health questionnaire, undergo a video or written consultation with a Juniper clinician, and receive their prescription directly through the service. This streamlined pathway reduces barriers to access that exist in the traditional healthcare system.
A full refund is available within 25 days of joining for members who decide the programme is not right for them. This offers a risk-reduction mechanism for those uncertain about committing to a monthly subscription for an extended period.
How Does Juniper Compare to Voy and Other Providers?
Juniper competes directly with providers like Voy in the UK, offering the same core medications, Wegovy and Mounjaro, with comparable overall cost, but with differences in customer support hours, refund policies, and the breadth of lifestyle coaching provided alongside medication.
Juniper vs. Voy Comparison:
| Feature | Juniper | Voy |
|---|---|---|
| Wegovy cost (UK) | From 164 GBP/month | From 144 GBP/month |
| Trustpilot rating | 4.5 (9k+ reviews) | 4.7 (17k+ reviews) |
| UK registered doctors | Yes | Yes |
| Customer support hours | 9am-5pm (days unspecified) | 8am-8pm everyday |
| Money-back policy | 25-day refund | Yes |
| Members | 260,000 globally | 100,000 UK |
Voy has a higher Trustpilot rating and longer customer support hours. Juniper has more members globally and a published clinical study supporting its programme outcomes. Both providers offer the same medications and require self-administered injections on a weekly schedule.
Is Juniper Better Than Other Weight Loss Apps?
Juniper differentiates itself from basic weight loss apps by combining prescription medication access with clinical supervision, lifestyle coaching, and a published study demonstrating superior results compared to medication alone, a claim most app-only solutions cannot support.
Weight loss apps without medication access produce modest results in the absence of pharmacological appetite suppression. Juniper’s combination of GLP-1 medication plus structured digital coaching achieves outcomes that neither element produces independently.
The programme’s clinical study, comparing Juniper’s cohort to SCALE and ADDRESS trial participants, provides an evidence base that sets Juniper apart from digital health providers that rely on testimonials rather than comparative clinical data.
How Much Does Juniper Cost?
Juniper costs from approximately 164 GBP per month in the UK for Wegovy, with pricing varying by medication, dose level, and market. This represents a significant monthly commitment that reflects the cost of both the GLP-1 medication and the clinical programme support bundled into the subscription.
The cost includes medication, clinician consultations, app access, and lifestyle coaching support. Unlike standard private prescriptions, Juniper members do not pay separately for each consultation. The programme fee covers the full care package for the entire membership period.
Members who cancel within 25 days receive a full refund. Beyond this window, cancellation policies apply on a rolling subscription basis. Insurance does not typically cover private digital health programmes of this type in the UK market.
Is Juniper Worth the Price?
For members who achieve the programme’s average 23% body weight reduction, Juniper’s combination of medication access, clinician support, and lifestyle coaching represents meaningful value, with outcomes that significantly exceed what self-managed medication use produces without programme support.
The cost of Juniper is comparable to purchasing Wegovy or Mounjaro through a standard private prescription and then paying separately for coaching and consultations. The bundled model may represent better value for members who would otherwise require multiple providers.
Long-term cost is a critical consideration. GLP-1 medications require continued use to maintain weight loss. Members who stop treatment typically regain a significant portion of lost weight. Building lasting habits during the programme reduces, but does not eliminate, this risk.
Will You Regain Weight After Stopping Juniper?
Yes. Research shows that patients regain significant weight after stopping GLP-1 medications, with studies indicating 50-65% of lost weight returns within 12 months of discontinuation when not supported by strong dietary and exercise habits established during treatment.
Juniper acknowledges this reality and builds habit formation into the programme specifically to reduce regain risk. The programme’s emphasis on exercise planning, nutritional guidance, and long-term behaviour change aims to leave members with tools that work after medication ends.
The body reverts to prior hunger patterns and metabolic tendencies when GLP-1 hormonal signalling is removed. Members who build protein-focused eating habits and resistance training routines during the programme demonstrate better long-term weight maintenance than those relying on medication alone.
How Do You Maintain Results After the Programme?
Maintaining weight loss after Juniper requires the continuation of the lifestyle habits built during the programme. The key habits are adequate protein intake (1.2-1.6 g per kg of body weight daily), regular resistance training, and a sustainable calorie-controlled dietary pattern.
Members who establish high-protein meal habits while on GLP-1 medication preserve more lean muscle mass during weight loss. Greater muscle mass sustains a higher resting metabolic rate after discontinuation, reducing the hormonal rebound that drives weight regain.
Structured resistance training, ideally started during the programme, builds and maintains the muscle that GLP-1-driven rapid weight loss tends to deplete. Members who combine medication with strength training consistently report better body composition and lower post-programme regain rates.
Should You Try Eat Proteins With the Juniper Programme?
Eat Proteins provides expert nutrition coaching specifically for GLP-1 programme members who want to preserve muscle, optimise protein intake, and build the sustainable habits that protect weight loss results after Juniper treatment ends. Medication opens the window. Eat Proteins helps you climb through it for good.
The core risk for Juniper members: rapid weight loss on GLP-1 medication burns both fat and lean muscle mass. Without deliberate protein intake of 1.2-1.6 g per kg (0.55-0.73 g per lb) daily, muscle loss accelerates. Lower muscle mass reduces resting metabolic rate, making weight regain significantly more likely.
The Eat Proteins approach pairs high-protein meal planning with structured resistance training guidance. These are the two evidence-backed strategies that most strongly predict sustained weight loss after GLP-1 treatment. You’re not just shrinking. You’re building the body that stays lean.
Why Do Our Experts at Eat Proteins Recommend Protein Coaching?
Our coaches at Eat Proteins work with GLP-1 programme members to build protein-rich eating patterns that persist after medication stops, targeting the nutritional gap that most Juniper members never fully address while focused on the scale number each week.
Resistance training combined with protein targets of 1.6 g per kg (0.73 g per lb) prevents the lean muscle loss that accompanies rapid fat reduction on GLP-1 drugs. Maintaining muscle keeps metabolic rate elevated, protecting against the weight regain that follows programme completion.
Patients who combine a digital weight loss programme like Juniper with structured nutrition coaching from Eat Proteins report better body composition outcomes and lower weight regain rates. The drug and the programme do the heavy lifting. Eat Proteins keeps the results in place.